The impact of concentration and administration time on the radiomodulating properties of undecylprodigiosin in vitro

1. Labay E, Efimova EV, Quarshie BK, Golden DW, Weichselbaum RR, Kron SJ. Ionizing radiation-induced foci persistence screen to discover enhancers of accelerated senescence. Int J High Throughput Screen 2011:2:1-13. doi: 10.2147/IJHTS.S17076Search in Google Scholar

2. Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 2005;7:1630-47. doi: 10.1089/ ars.2005.7.1630Search in Google Scholar

3. Hazra B, Ghosh S, Kumar A, Pandey BN. The prospective role of plant products in radiotherapy of cancer: a current overview. Front Pharmacol 2012;2:94. doi: 10.3389/ fphar.2011.00094Search in Google Scholar

4. Rosenberg A, Knox S. Radiation sensitization with redox modulators: a promising approach. Int J Radiat Oncol Biol Phys 2006;64:343-54. doi: 10.1016/j.ijrobp.2005.10.013Search in Google Scholar

5. Papazisis KT, Zambouli D, Kimoundri OT, Papadakis ES, Vala V, Geromichalos GD, Voyatzi S, Markala D, Destouni E, Boutis L, Kortsaris AH. Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation. Cancer Lett 2000;160:107-13. doi: 10.1016/S0304-3835(00)00569-3Search in Google Scholar

6. Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 2011;11:239-53. doi: 10.1038/nrc3007Search in Google Scholar

7. Joksic G, Leskovac A, Petrovic S. Modulation of radiationinduced damage by Serbian natural plant products: implications for radioprotection. In: Arora R, editor. Herbal radiomodulators: applications in medicine, homeland defence and space. Oxfordshire: CAB International; 2008. p. 67-82.10.1079/9781845933951.0067Search in Google Scholar

8. Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov 2013;12:526-42. doi: 10.1038/nrd4003Search in Google Scholar

9. Burris HA, 3rd, Hurtig J. Radiation recall with anticancer agents. Oncologist 2010;15:1227-37. doi: 10.1634/ theoncologist.2009-0090Search in Google Scholar

10. Thomson NR, Crow MA, McGowan SJ, Cox A, Salmond GP. Biosynthesis of carbapenem antibiotic and prodigiosin pigment in Serratia is under quorum sensing control. Mol Microbiol 2000;36:539-56. doi: 10.1046/j.1365-2958. 2000.01872.xSearch in Google Scholar

11. Hobbs G, Frazer CM, Gardner DCJ, Flett F, Oliver SG. Pigmented antibiotic production by Streptomyces coelicolor A3(2): kinetics and the influence of nutrients. J Gen Microbiol 1990;136:2291-6. doi: 10.1099/00221287-136-11-2291Search in Google Scholar

12. Kawasaki T, Sakurai F, Hayakawa Y. A prodigiosin from the roseophilin producer Streptomyces griseoviridis. J Nat Prod 2008;71:1265-7. doi: 10.1021/np7007494Search in Google Scholar

13. Nakamura A, Magae J, Tsuji RF, Yamasaki M, Nagai K. Suppression of cytotoxic T cell induction in vivo by prodigiosin 25-C. Transplantation 1989;47:1013-6. doi: 10.1097/00007890-198906000-00019Search in Google Scholar

14. Songia S, Mortellaro A, Taverna S, Fornasiero C, Scheiber EA, Erba E, Colotta F, Mantovani A, Isetta AM, Golay J. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets. J Immunol 1997;158:3987-95. PMID: 9103470Search in Google Scholar

15. Tsuji RF, Magae J, Yamashita M, Nagai K, Yamasaki M. Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells. J Antibiot (Tokyo) 1992;45:1295-302. PMID: 139985110.7164/antibiotics.45.12951399851Search in Google Scholar

16. Pandey R, Chander R, Sainis KB. Prodigiosins as anti cancer agents: living upto their name. Curr Pharm Design 2009;15:732-41. doi: 10.2174/138161209787582192Search in Google Scholar

17. Yamamoto C, Takemoto H, Kuno K, Yamamoto D, Nakai K, Baden T, Kamata K, Hirata H, Watanabe T, Inoue K. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human colon cancer cell lines in vitro. Oncol Rep 2001;8:821-4. PMID: 1141079110.3892/or.8.4.82111410791Search in Google Scholar

18. Yamamoto D, Kiyozuka Y, Uemura Y, Yamamoto C, Takemoto H, Hirata H, Tanaka K, Hioki K, Tsubura A. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human breast cancer cell lines. J Cancer Res Clin Oncol 2000;126:191-7. doi: 10.1007/s004320050032Search in Google Scholar

19. Chang CC, Chen WC, Ho TF, Wu HS, Wei YH. Development of natural anti-tumor drugs by microorganisms. J Biosci Bioeng 2011;111:501-11. doi: 10.1016/j.jbiosc.2010.12.026Search in Google Scholar

20. Ho TF, Ma CJ, Lu CH, Tsai YT, Wei YH, Chang JS, Lai JK, Cheuh PJ, Yeh CT, Tang PC, Tsai Chang J, Ko JL, Liu FS, Yen HE, Chang CC. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53. Toxicol Appl Pharmacol 2007;225:318-28. doi: 10.1016/j.taap.2007.08.007Search in Google Scholar

21. Liu P, Wang YY, Qi X, Gu Q, Geng M, Li J. Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome. PLoS One 2013;8:e65381. doi: 10.1371/ journal.pone.0065381Search in Google Scholar

22. Nikodinovic-Runic J, Mojic M, Kang Y, Maksimovic-Ivanic D, Mijatovic S, Vasiljevic B, Stamenkovic VR, Senerovic L. Undecylprodigiosin conjugated monodisperse gold nanoparticles efficiently cause apoptosis in colon cancer cells in vitro. J Mater Chem B. 2014;2:3271-81. doi: 10.1039/ C4TB00300DSearch in Google Scholar

23. Stankovic N, Senerovic L, Ilic-Tomic T, Vasiljevic B, Nikodinovic-Runic J. Properties and applications of undecylprodigiosin and other bacterial prodigiosins. Appl Microbiol Biotechnol 2014;98:3841-58. doi: 10.1007/ s00253-014-5590-1Search in Google Scholar

24. Stankovic N, Radulovic V, Petkovic M, Vuckovic I, Jadranin M, Vasiljevic B, Nikodinovic-Runic J. Streptomyces sp. JS520 produces exceptionally high quantities of undecylprodigiosin with antibacterial, antioxidative, and UV-protective properties. Appl Microbiol Biotechnol 2012;96:1217-31. doi: 10.1007/s00253-012-4237-3Search in Google Scholar

25. Leiros M, Alonso E, Sanchez JA, Rateb ME, Ebel R, Houssen WE, Jaspars M, Alfonso A, Botana LM. Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons. ACS Chem Neurosci 2014;5:71-80. doi: 10.1021/cn4001878Search in Google Scholar

26. Boric M, Danevcic T, Stopar D. Prodigiosin from Vibrio sp. DSM 14379; a new UV-protective pigment. Microb Ecol 2011;62:528-36. doi: 10.1007/s00248-011-9857-0Search in Google Scholar

27. Law on health care. Official Gazette of the Republic of Serbia. Parliament of the Republic of Serbia. 2005. 107:112-161.Search in Google Scholar

28. Shukla S, Anjaria K, Bhat N, Shirsath K, Sreedevi B. Effect of caffeine on radiation induced micronuclei in human lymphocytes. Radiat Protect Environ 2010;33:195-8 [displayed 11 January 2017]. Available at http://www.rpe.org.in/article.asp?issn=0972-0464;year=2010;volume=33;issue=4;spage=195;epage=198;aulast=ShuklaSearch in Google Scholar

29. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993;285:35-44. doi: 10.1016/0027-5107(93)90049-LSearch in Google Scholar

30. Surralles J, Xamena N, Creus A, Marcos R. The suitability of the micronucleus assay in human lymphocytes as a new biomarker of excision repair. Mutat Res 1995;342:43-59. doi: 10.1016/0165-1218(95)90089-6Search in Google Scholar

31. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Weinheim: Verlag Chemie; 1974. p. 673-6.10.1016/B978-0-12-091302-2.50032-3Search in Google Scholar

32. Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JM. The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)- iron(III) complex. Biochem J 1989;258:617-20. doi: 10.1042/ bj2580617Search in Google Scholar

33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75. PMID: 1490771310.1016/S0021-9258(19)52451-6Search in Google Scholar

34. Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012;9:193-9. doi: 10.7150/ijms.3635Search in Google Scholar

35. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine. 4 ed. Oxford: Oxford University Press; 2007.Search in Google Scholar

36. Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett 2012;327:48-60. doi: 10.1016/j.canlet.2011.12.012Search in Google Scholar

37. Roninson IB, Broude EV, Chang B-D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001;4:303-13. doi: 10.1054/drup.2001.0213Search in Google Scholar

38. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008;15:1153-62. doi: 10.1038/cdd.2008.47Search in Google Scholar

39. Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009;35:32-46. doi: 10.1016/j.ctrv.2008.07.004Search in Google Scholar

40. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95. doi: 10.1152/ physrev.00018.2001Search in Google Scholar

41. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991;51:794-8. PMID: 1846317 Search in Google Scholar